Log in

OTCMKTS:DSRLF - DiaSorin Stock Price, Forecast & News

0.00 (0.00 %)
(As of 01/29/2020)
Today's Range
Now: $128.00
50-Day Range
MA: $130.31
52-Week Range
Now: $128.00
Volume176 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
DiaSorin S.p.A. develops, produces, and commercializes diagnostic tests in various clinical areas for hospital and private testing laboratories in the market of immunodiagnostics and molecular diagnostics. It offers immunodiagnostics products in the areas of infectious diseases; bone and mineral metabolism; endocrinology, including diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology; hypertension; oncology; stool diagnostics; autoimmunity; and cardiac and brain damages. The company's immunodiagnostics systems include LIAISON XL, an automated chemiluminescence analyzer; LIAISON analyzer; EVOlyzer 2-150/8 with disposable tips to automate microplate based assays; and ETI Max 3000, an automated microtiter plate analyzer. It also offers molecular diagnostic products LIAISON MDX a thermocycler; and LIAISON IAM, an instrument for amplification of nucleic acids, as well as kits, PCR master mixes, primer pairs, and molecular controls for monitoring oncology and infectious diseases. The company sells its products directly, as well as through an international network of independent distributors in Europe, Africa, North Americam Central America, South America, and the Asia Pacific. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual SalesN/A



Next Earnings Date4/27/2020 (Estimated)
OptionableNot Optionable

Receive DSRLF News and Ratings via Email

Sign-up to receive the latest news and ratings for DSRLF and its competitors with MarketBeat's FREE daily newsletter.

DiaSorin (OTCMKTS:DSRLF) Frequently Asked Questions

What is DiaSorin's stock symbol?

DiaSorin trades on the OTCMKTS under the ticker symbol "DSRLF."

When is DiaSorin's next earnings date?

DiaSorin is scheduled to release their next quarterly earnings announcement on Monday, April 27th 2020. View Earnings Estimates for DiaSorin.

Has DiaSorin been receiving favorable news coverage?

News headlines about DSRLF stock have trended somewhat positive this week, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. DiaSorin earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for DiaSorin.

What other stocks do shareholders of DiaSorin own?

Who are DiaSorin's key executives?

DiaSorin's management team includes the folowing people:
  • Mr. Carlo Rosa, CEO, GM & Exec. Director (Age 53)
  • Dr. Chen Menachem Even, Chief Commercial Officer & Exec. Director (Age 56)
  • Mr. Piergiorgio Pedron, Corp. Accounting Documents Officer, CFO & Sr. Corp. VP (Age 48)
  • Mr. Riccardo Fava, Sr. Director of Investor Relations & Corp. Communication
  • Mr. Marco Minolfo, Mang. of the Corp. Legal Affairs Department

How do I buy shares of DiaSorin?

Shares of DSRLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is DiaSorin's stock price today?

One share of DSRLF stock can currently be purchased for approximately $128.00.

MarketBeat Community Rating for DiaSorin (OTCMKTS DSRLF)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  65 (Vote Outperform)
Underperform Votes:  82 (Vote Underperform)
Total Votes:  147
MarketBeat's community ratings are surveys of what our community members think about DiaSorin and other stocks. Vote "Outperform" if you believe DSRLF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DSRLF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Featured Article: Analyst Ratings Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel